Bank of Montreal
RDHL

Bank of Montreal’s Redhill Biopharma RDHL Stock Holding History

Bank of Montreal’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5
Closed -$30K – 4680
2021
Q1 		$30K Buy
5
+4
+400% +$33.6K ﹤0.01% 3908
2020
Q4 		$5K Buy
+1
New +$8.99K ﹤0.01% 4766

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Bank of Montreal's RDHL Position: Q2 2021 in Review

Bank of Montreal sold out of Redhill Biopharma (RDHL) in Q2 2021, closing a stake of 5 shares — an estimated $30K sold.

Bank of Montreal first reported a position in RDHL in Q4 2020 and held it in 2 quarters. The position peaked at $30K in Q1 2021. 48 funds tracked by Wall St. Rank hold RDHL as of Q2 2021.

  • Bank of Montreal reported no remaining Redhill Biopharma position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 5 Redhill Biopharma shares in Q2 2021, an estimated $30K.
  • Bank of Montreal first reported a position in Redhill Biopharma in Q4 2020 and held it in 2 quarters.
  • Bank of Montreal's Redhill Biopharma position peaked at $30K in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.